Telemedicine vs hospital based medicine for assessment of Helicobacter pylori eradication: randomised controlled trial

Telemedicine vs hospital based medicine for assessment of Helicobacter pylori eradication: randomised controlled trial - RCT of Telemedicine for assessment of Helicobacter pylori eradication

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034749

Enrollment

172

Registered

2018-11-06

Start date

2018-11-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Telemedicine:Urea breath test at home by patient and breath bag is sent by post for the assessment of Helicobacter pylori eradication success and result description by the telemedicine system Hospital

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)A patient with Helicobacter pylori infection without history of eradication therapy (2)A patient who is willing to eradicate the Helicobacter pylori with triple therapy (containing amoxicillin + clarithromycin or metronidazole) (3)A patient who understand the risk of telemedicine system, agreed the terms of use and expected to participate (4)A patient who agreed not to storage or leak the video and voice of telemedicine (5)A patient who give a written informed consent

Exclusion criteria

Exclusion criteria: (1)Patients allergic to penicillin (2)Pregnancy (3)Lactation (4)A patient with brain and spinal cord disease (5)A patient with infectious mononucleosis (6)Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction

Design outcomes

Primary

Measure	Time frame
Eradication rate (ITT analysis) and assessment of burden by questionnaire	—

Secondary

Measure	Time frame
Eradication rate (PP analysis)	—

Countries

Japan

Contacts

Public ContactSoichiro Sue

Yokohama City University Hospital Gastroenterology

ssue@yokohama-cu.ac.jp045-787-2326

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026